表 2. Multivariate analysis of factors influencing overall survival (OS) of patients with overall recurrence.
影响整体复发患者OS的多因素Cox回归分析
Variables | OS | ||
Hazard ratio | 95%CI | P | |
ER, PR, follow-up, CT, RT,CI: For details see the notes of table 1. | |||
Age | |||
<60 yr. | 1.000 | Ref | |
≥60 yr. | 1.107 | 0.531-2.306 | 0.786 |
FIGO stage | |||
Ⅰ | 1.000 | Ref | |
Ⅱ | 4.583 | 1.041-20.174 | 0.044 |
Ⅲ | 4.918 | 1.638-14.764 | 0.005 |
Grade | |||
1 | 1.000 | Ref | |
2 | 1.102 | 0.132-9.180 | 0.929 |
3 | 1.733 | 0.198-15.187 | 0.619 |
Pathological type | |||
Endometrioid carcinoma | 1.000 | Ref | |
Special types | 1.064 | 0.502-2.252 | 0.872 |
Myometrial invasion | |||
<1/2 | 1.000 | Ref | |
≥1/2 | 1.885 | 0.858-4.141 | 0.114 |
Cervical stromal invasion | |||
No | 1.000 | Ref | |
Yes | 0.868 | 0.325-2.317 | 0.777 |
Lymphadenectomy | |||
Yes | 1.000 | Ref | |
No | 1.553 | 0.701-3.439 | 0.278 |
Ki-67 positive percentage | 1.005 | 0.988-1.022 | 0.589 |
ER positive percentage | 0.992 | 0.978-1.005 | 0.228 |
PR positive percentage | 0.977 | 0.962-0.992 | 0.003 |
P53 positive percentage | 1.008 | 0.998-1.018 | 0.111 |
Adjuvant therapy | |||
Follow-up | 1.000 | Ref | |
Only CT | 2.421 | 0.838-6.994 | 0.102 |
Only RT | 0.691 | 0.314-1.521 | 0.358 |
CT and RT | 1.625 | 0.306-8.630 | 0.569 |